A phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell lung cancer (NSCLC).
about
Effect of veliparib (ABT-888) on cardiac repolarization in patients with advanced solid tumors: a randomized, placebo-controlled crossover study.Clinical Pharmacokinetics and Mass Balance of Veliparib in Combination with Temozolomide in Subjects with Nonhematologic Malignancies.Phase 1 dose-escalation study of single-agent veliparib in Japanese patients with advanced solid tumors.PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer.Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer.Parent-Metabolite Pharmacokinetic Modeling and Pharmacodynamics of Veliparib (ABT-888), a PARP Inhibitor, in Patients With BRCA 1/2-Mutated Cancer or PARP-Sensitive Tumor Types.Population pharmacokinetics and site of action exposures of veliparib with topotecan plus carboplatin in patients with haematological malignancies.
P2860
Q37373164-60808EBA-6C01-48EF-BA91-30F9048C36AEQ38790159-DD952B34-21C5-42E2-BFAF-EBE80B22A069Q41595492-48F9CE77-35C1-48FF-A4E5-67AFE485DCF4Q42517340-941709C3-F6C2-429A-A836-A8D48B9E8C24Q46753331-7BFF0654-D7E1-4987-A660-F54F51BDD7DAQ52777824-F1135C2A-FEA7-4491-B1D8-95AE0A480318Q53529517-101A0E69-83FA-4C5E-B0AC-94BB744DFF3D
P2860
A phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell lung cancer (NSCLC).
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A phase 1 study evaluating the ...... mall cell lung cancer (NSCLC).
@ast
A phase 1 study evaluating the ...... mall cell lung cancer (NSCLC).
@en
type
label
A phase 1 study evaluating the ...... mall cell lung cancer (NSCLC).
@ast
A phase 1 study evaluating the ...... mall cell lung cancer (NSCLC).
@en
prefLabel
A phase 1 study evaluating the ...... mall cell lung cancer (NSCLC).
@ast
A phase 1 study evaluating the ...... mall cell lung cancer (NSCLC).
@en
P2093
P2860
P1476
A phase 1 study evaluating the ...... small cell lung cancer (NSCLC)
@en
P2093
Hidehito Horinouchi
Hidenori Mizugaki
Hideyuki Hashiba
Hiroshi Nokihara
Noboru Yamamoto
Satoru Kitazono
Shigehiro Yagishita
Shintaro Kanda
P2860
P2888
P304
P356
10.1007/S00280-015-2876-7
P577
2015-10-03T00:00:00Z
P5875
P6179
1032705317